It's on the list again! "Report on Scientific and Technological Competitiveness of Large Varieties of Traditional Chinese Medicine (2017 Edition)" Publishes Houyanqing Oral Liquid as a List of Scientific and Technological Competitiveness
On November 28, 2017, at the Third Forum of the Alliance of Large Varieties of Traditional Chinese Medicine held in Guangzhou, the Chinese Academy of Traditional Chinese Medicine issued the Report on the Competitiveness of Science and Technology of Large Varieties of Traditional Chinese Medicine (2017 edition). Hunan Times Sunshine Pharmaceutical Co., Ltd. produces the national exclusive variety Houyanqing Oral Liquid, ranking fifth in the scientific and technological competitiveness of large varieties of traditional Chinese medicines used in the Department of five senses.
The report on the scientific and technological competitiveness of large varieties of Chinese medicines (2017 edition) is divided into five chapters, which briefly introduces the general situation of scientific and technological research on large varieties of Chinese medicines. The scientific and technological evaluation model system of large varieties of traditional Chinese medicine includes evaluation index system, weight factor investigation, and outline of selected varieties. It is understood that there are about 60,000 Chinese patent medicine approvals in China at present. According to the evaluation model system and according to the weight factor algorithm rules, the score value of the former is ranked in the "Science and Technology Competitiveness List".
After strict scoring, Houyanqing Oral Liquid, a professional Chinese patent medicine for pharynx and throat in the Sunshine Pharmaceutical Industry of the times, was successfully selected as the "Science and Technology Competitiveness List" and ranked fifth in the "Science and Technology Competitiveness List of Large Varieties of Chinese Traditional Medicine for Five Facial Facial Sciences". Houyanqing Oral Liquid is developed independently by Time Sunshine Pharmaceutical Industry. It is a national key new product with independent intellectual property rights. It has been on the market for many years for continuous quality technology improvement and clinical reappraisal research. The quality and efficacy of the product have been highly recognized by patients and doctors.
Record No.：Hunan ICP preparation11019517Number-1